Access Keys:
Skip to content (Access Key - 0)

Thomas King

The Future of Collaborative IT - the Translational Research Institute

The TRI is a joint venture between The University of Queensland Diamantina Institute, Queensland University of Technology’s Institute of Health and Biomedical Innovation, Mater Medical Research Institute and the Princess Alexandra Hospital’s Centres for Health Research. The TRI has been made possible through $354 million in funding which was provided by the Australian and Queensland Governments, The Atlantic Philanthropies, UQ and QUT.
The centre was the vision of 2006 Australian of the Year Professor Ian Frazer – inventor of the cervical cancer vaccine (HPV) – and the Mater Medical Research Institute. This presentation will outline the IT systems being deployed as part of the TRI including a 100 rack tier 2 data centre, telephony, building and data centre networks, research computing and storage and AV systems (including telepresence, digital signage and video walls). The presentation will also outline how a single physical network of over 5,500 cat 6a data outlets will be utilised by all the stakeholder groups including QLD Health.

(tick)

Thomas King's Biography
To be provided